Pancreatic Cancer Research

ResearcherChampalimaud FoundationActive in the last 2 years

Jacques M.E. Deviere

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1889-1924; OpenAlex author ID A5103178513. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
32
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: retrospective study. Co-author DOI 10.1093/bjsopen/zrae134↗
  2. The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine. Last author DOI 10.1159/000509197↗
  3. The Impact of Recent Advances in Endoscopic Ultrasound-Guided Tissue Acquisition on the Management of Pancreatic Cancer. Last author DOI 10.1159/000510730↗
  4. Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. Co-author DOI 10.1016/j.gie.2019.06.032↗
  5. Feasibility of Immunohistochemistry on Endoscopic Ultrasound Fine-Needle Aspiration Samples for Evaluating Predictive Biomarkers in Pancreatic Cancer Managemen… Co-author DOI 10.1097/mpa.0000000000000672↗
  6. Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Co-author DOI 10.1053/j.gastro.2012.06.006↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susana Marques · 2 shared papers, 2021 · strength 0.34
  2. Miguel Bispo · 2 shared papers, 2021 · strength 0.34
  3. Pieter Demetter · 3 shared papers, 2012–2024 · strength 0.27
  4. Jean‐Luc Van Laethem · 3 shared papers, 2012–2024 · strength 0.27
  5. Jean Closset · 2 shared papers, 2012–2024 · strength 0.21
  6. Julie Navez · 1 shared paper, 2024 · strength 0.19
  7. Nicky D’Haene · 1 shared paper, 2024 · strength 0.19
  8. Maria Antonietta Bali · 1 shared paper, 2024 · strength 0.19
  9. Marie-Lucie Racu · 1 shared paper, 2024 · strength 0.19
  10. Christelle Bouchart · 1 shared paper, 2024 · strength 0.19
  11. Oier Azurmendi Senar · 1 shared paper, 2024 · strength 0.19
  12. Tatjana Arsenijevic · 1 shared paper, 2024 · strength 0.19
  13. Hiroyuki Isayama · 1 shared paper, 2019 · strength 0.09
  14. Stuart Sherman · 1 shared paper, 2019 · strength 0.09
  15. Guido Costamagna · 1 shared paper, 2019 · strength 0.09
  16. Richard A. Kozarek MD · 1 shared paper, 2019 · strength 0.09
  17. Dong Wan Seo · 1 shared paper, 2019 · strength 0.09
  18. Yousuke Nakai · 1 shared paper, 2019 · strength 0.09
  19. Kulwinder S. Dua · 1 shared paper, 2019 · strength 0.09
  20. Raphaël Maréchal · 2 shared papers, 2012–2016 · strength 0.08
  21. Jean‐Baptiste Bachet · 2 shared papers, 2012–2016 · strength 0.08
  22. Francesco Puleo · 1 shared paper, 2016 · strength 0.05
  23. Philippe R Rougier · 1 shared paper, 2012 · strength 0.02
  24. Magali Svrcek · 1 shared paper, 2012 · strength 0.02
  25. Anne Couvelard Benveniste · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.